Journal of Next Generation Sequencing & Applications

Journal of Next Generation Sequencing & Applications
Open Access

ISSN: 2469-9853

+44-1647-403003

Citations Report

Citations Report - Journal of Next Generation Sequencing & Applications [143 Articles]

The articles published in Journal of Next Generation Sequencing & Applications have been cited 143 times by eminent researchers all around the world. Following is the list of articles that have cited the articles published in Journal of Next Generation Sequencing & Applications.

Greaves M. (2018) Nothing in cancer makes sense except…. BMC biology 16: 22.

Nevedomskaya E, Baumgart SJ, Haendler B (2018) Recent Advances in Prostate Cancer Treatment and Drug Discovery. International journal of molecular sciences 19: 1359.

Chowell-Puente D. Mathematical and computational models of cancer and the immune system. Arizona State University; 2016.

Risom T. Measuring And Managing Phenotypic Heterogeneity And Plasticity In Breast Cancer To Improve Therapeutic Control.

Al-Lazikani B, Workman P. Minimizing bias in target selection by exploiting multidisciplinary Big Data and the protein interactome.

Stenzinger A, Weichert W. Genetic Profiling of Cancers of the Digestive System: Biological Insights and Clinical Implications. Pathobiology. 2017;84(6):306-22.

Karlsson K. Counting molecules in cell-free DNA and single cells RNA. Inst för medicinsk biokemi och biofysik/Dept of Medical Biochemistry and Biophysics; 2016 Mar 8.

Vodák D, Lorenz S, Nakken S, Aasheim LB, Holte H, Bai B, Myklebost O, Meza-Zepeda LA, Hovig E. Sample-Index Misassignment Impacts Tumour Exome Sequencing. Scientific reports. 2018 Mar 28;8(1):5307.

Tsongalis GJ, Coleman WB. Somatic mutation analysis of human cancers: challenges in clinical practice. The Journal of Clinical Pharmacology. 2017 Oct 1;57(S10).

Gonzalez-Rivera M, Picornell AC, Alvarez EL, Martin M. A cross-sectional comparison of druggable mutations in primary tumors, metastatic tissue, circulating tumor cells, and cell-free circulating DNA in patients with metastatic breast cancer: the MIRROR study protocol. JMIR research protocols. 2016 Jul;5(3).

Tanaka M, Yoshimoto T, Nakamura T. A double‐edged sword: The world according to Capicua in cancer. Cancer science. 2017 Dec;108(12):2319-25.

Guerini-Rocco E, Passaro A, Casadio C, De Luca VM, Guarize J, de Marinis F, Vacirca D, Barberis M. Acquired Resistance to Tyrosine Kinase Inhibitors in Non–Small Cell Lung Cancers: The Role of Next-Generation Sequencing on Endobronchial Ultrasound–Guided Transbronchial Needle Aspiration Samples. Archives of pathology & laboratory medicine. 2018 Apr;142(4):465-73.

Guerini-Rocco E, Passaro A, Casadio C, De Luca VM, Guarize J, de Marinis F, Vacirca D, Barberis M. Acquired Resistance to Tyrosine Kinase Inhibitors in Non–Small Cell Lung Cancers: The Role of Next-Generation Sequencing on Endobronchial Ultrasound–Guided Transbronchial Needle Aspiration Samples. Archives of pathology & laboratory medicine. 2018 Apr;142(4):465-73.

Martínez-Jiménez F, Overington JP, Al-Lazikani B, Marti-Renom MA. Rational design of non-resistant targeted cancer therapies. Scientific reports. 2017 Apr 24;7:46632.

Grizzi F. Cancer heterogeneity and drug metabolism: what we know and what we need to know.

Romano G, Chen PL, Song P, McQuade JL, Liang RJ, Liu M, Roh W, Duose DY, Carapeto FC, Li J, Teh JL. A preexisting rare PIK3CAE545K subpopulation confers clinical resistance to MEK plus CDK4/6 inhibition in NRAS melanoma and is dependent on S6K1 signaling. Cancer discovery. 2018 Mar 1.

Venkatesan S, Rosenthal R, Kanu N, McGranahan N, Bartek J, Quezada SA, Hare J, Harris RS, Swanton C. Perspective: APOBEC mutagenesis in drug resistance and immune escape in HIV and cancer evolution. Annals of Oncology. 2018 Jan 8;29(3):563-72.

Snowden E, Porter W, Hahn F, Ferguson M, Tong F, Parker JS, Middlebrook A, Ghanekar S, Dillmore WS, Blaesius R. Immunophenotyping and transcriptomic outcomes in PDX-derived TNBC tissue. Molecular Cancer Research. 2016 Jan 1:molcanres-0286.

Cannataro VL, Gaffney SG, Stender C, Zhao ZM, Philips M, Greenstein AE, Townsend JP. Heterogeneity and mutation in KRAS and associated oncogenes: evaluating the potential for the evolution of resistance to targeting of KRAS G12C. Oncogene. 2018 May;37(18):2444.

Cannataro VL, Gaffney SG, Stender C, Zhao ZM, Philips M, Greenstein AE, Townsend JP. Heterogeneity and mutation in KRAS and associated oncogenes: evaluating the potential for the evolution of resistance to targeting of KRAS G12C. Oncogene. 2018 May;37(18):2444.

Top